Yea, I think the point-in-time, annualized R&D expense on 2023/03 will be the midpoint of the reported figure for 2022 and 20221. (~$30bn, where EOY 2022 was $3

Yea, I think the point-in-time, annualized R&D expense on 2023/03 will be the midpoint of the reported figure for 2022 and 20221. (~$30bn, where EOY 2022 was $35bn and EOY 2021 was $24.6bn). The layoff, we can imagine, impacted maybe 15% of R&D at most. It might still be too high in 2023, depending on what their revenue figures do in Q1/Q2. Would be interesting if they needed to do another layoff -- doesn't seem outside the realm of possibility.